Notice of Intent to Publish a Funding Opportunity for NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
ID: 357369Type: Forecasted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $700K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is forecasting a funding opportunity titled "NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity," which aims to support research initiatives that address the intersection of substance use and racial equity. This grant program, utilizing the DP1 activity code, is designed to foster meaningful collaborations and innovative projects in this critical area of health research. With an estimated total program funding of $3.5 million and an award ceiling of $700,000, the anticipated application period will open in Fall 2025, following the expected publication of the notice of funding opportunity in Spring 2025. Interested applicants should prepare to submit their proposals by the estimated closing date of October 14, 2025, with awards expected to be made by July 1, 2026.

    Point(s) of Contact
    No information provided.
    Files
    No associated files provided.
    Similar Opportunities
    Notice of Intent to Publish a Funding Opportunity Announcement for NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the initiative titled "NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use," aimed at addressing HIV-related health disparities in underserved racial and/or ethnic populations. This funding opportunity will solicit research applications that propose novel approaches to tackle these critical health issues, with a focus on fostering meaningful collaborations among applicants. The estimated total program funding for this initiative is $2,000,000, with the NOFO expected to be published in Summer 2025 and applications due in Winter 2025. Interested researchers should prepare to submit their proposals by the anticipated deadlines, with awards expected to be made by July 1, 2026.
    Notice of Intent to Publish a Funding Opportunity Announcement for NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the initiative titled "NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use," aimed at addressing HIV-related health disparities in underserved racial and ethnic populations. This initiative seeks to solicit research applications that propose novel approaches to tackle these critical health issues, thereby promoting equity in health outcomes. The estimated total program funding for this opportunity is $2,000,000, with the NOFO expected to be published in Summer 2025 and applications due in Winter 2025. Interested applicants should prepare to submit their proposals by the anticipated deadlines, with awards expected to be made by July 1, 2026.
    Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for pilot and exploratory research projects focused on health equity related to tobacco, alcohol, and cannabis use. The initiative aims to investigate disparities in exposure and usage of these substances by examining new or adapted policies in the U.S., with the goal of advancing equitable health policies. This funding opportunity will utilize the R21 grant mechanism, which supports early-stage research, and is expected to be published in September 2024, with the first application deadline in March 2025. Interested applicants should prepare their proposals in advance, as the estimated award date is December 1, 2025, and further details, including a pre-application webinar, will be announced following the NOFO publication.
    Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for research projects focused on health equity related to tobacco, alcohol, and cannabis policies. This initiative aims to address disparities in exposure and use of these substances by examining new or adapted policies in the U.S., with the goal of advancing equitable health policies. The funding opportunity will utilize the R01 grant mechanism, which is optional for clinical trials, and is expected to open for applications in February 2025, with a funding ceiling of $499,999. Interested applicants should prepare their proposals in advance, as the NOFO is anticipated to be published in September 2024, and further details, including a pre-application webinar, will be announced following the publication.
    Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity announcement for research aimed at accelerating the pace of substance use research using existing data, specifically under the R01 grant mechanism. This initiative seeks to promote innovative research projects that leverage existing datasets to enhance understanding and treatment of substance use disorders, with the goal of fostering meaningful collaborations among researchers. The estimated total program funding is $2 million, with approximately three awards expected to be made, and the anticipated application due date is in Spring 2025, following the publication of the Notice of Funding Opportunity in Fall 2024. For further details, potential applicants should prepare to submit their proposals by the estimated close date of June 17, 2025, with awards expected to be announced by April 1, 2026.
    Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at accelerating substance use research through the utilization of existing data, specifically under the R21 grant mechanism. This initiative seeks to foster innovative research projects that leverage pre-existing datasets to enhance understanding and treatment of substance use disorders. The total estimated funding for this program is $2 million, with an award ceiling of $200,000 per project and an anticipated three awards to be made. Interested applicants should note that the NOFO is expected to be published in Fall 2024, with applications due in Spring 2025, and the estimated award date is set for April 1, 2026.
    Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "Accelerating the Pace of Substance Use Research Using Existing Data." This initiative invites applications that propose innovative analyses of existing social science, behavioral, administrative, and neuroimaging data to investigate the etiology and epidemiology of substance use behaviors and related disorders, including HIV prevention and health service utilization. The program aims to leverage public datasets to enhance understanding of substance use trajectories and effective prevention strategies, particularly focusing on underrepresented populations and health disparities. A total funding commitment of $2 million is available for fiscal year 2026, with applications due by January 25, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for the initiative titled "Transformative Research to Address Health Disparities and Advance Health Equity" (U01 Clinical Trial Optional). This funding opportunity aims to foster innovative research projects that address significant health disparities and promote health equity, encouraging collaborations among researchers. The estimated total program funding is $3 million, with an award ceiling of $500,000 per project, and the application period is expected to open on December 10, 2024, with a closing date of February 28, 2025. Interested applicants should prepare to submit their proposals by the deadline, as the estimated award date is September 1, 2025.
    High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)" aimed at supporting innovative research that addresses the intersection of HIV and substance use. This initiative invites applications from individual researchers and research teams to develop projects that can lead to new prevention, treatment, and care strategies for individuals affected by both conditions, with a requirement for a detailed research plan and preliminary data. A total budget of $3.0 million is available for funding one to two awards, with individual project budgets capped at $1.5 million per fiscal year, and applications are due by February 12, 2027. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to consult with NIDA program staff early in the application process.
    NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDA Avant-Garde Program for HIV and Substance Use Disorder Research, a federal grant opportunity aimed at supporting innovative research proposals that address the intersection of HIV/AIDS and substance use disorders. This program seeks to fund exceptionally creative scientists who can propose high-impact studies that diverge significantly from existing research paths, with a focus on transformative approaches to prevention and treatment. The grant provides funding of up to $700,000 annually for a maximum duration of five years, with a submission deadline of August 14, 2025. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.